Blazing Star Merger Sub, Inc. announces Tender Offer and Consent Solicitation for any and all Walgreens Boots Alliance, Inc.'s 3.600% senior notes due 2025, 2.125% senior notes due 2026, 3.450% notes due 2026, 8.125% notes due 2029, 3.200% Notes due 2030, 4.500% senior notes due 2034, 4.800% senior notes due 2044, 4.650% notes due 2046 and 4.100% Notes due 2050, and any and all of Walgreen Co.'s 4.400% notes due 2042
Concurrently with the Tender Offer, the Offeror is soliciting consents (the "Consent Solicitation") (i) from holders of the 2025 Notes, the 2.125% 2026 Notes, the 2034 Notes and the 2044 Notes to certain proposed amendments to the indenture, dated as of
The Tender Offer and Consent Solicitation are being made in connection with, and are expressly conditioned upon the substantially concurrent closing of the acquisition of WBA pursuant to the agreement and plan of merger, dated
Upon the terms and subject to the conditions set forth in the Offer to Purchase and Consent Solicitation Statement relating to the Notes (as it may be amended or supplemented from time to time, the "Offer to Purchase and Consent Solicitation Statement"), the Offeror will pay to each holder who validly tenders (and does not validly withdraw) their Notes and validly delivers (and does not validly revoke) Consents on or prior to
The total consideration ("Total Consideration") payable for the Notes validly tendered at or prior to the Early Tender Date will be a price per
The Tender Offer and Consent Solicitation are scheduled to expire at
Title of |
CUSIP/ISIN(4) |
Outstanding |
Reference |
Bloomberg |
Fixed Spread |
Early Tender |
|
3.600% |
ISIN: XS1138359663 |
GBP£300,000,000 |
3.500% UKT |
FIT GLT0-10 |
+20 |
£50.00 |
|
2.125% |
ISIN: XS1138360166 |
EUR€750,000,000 |
0.000% DBR |
FIT GE1-3 |
+20 |
€50.00 |
|
3.450% |
CUSIP: 931427AQ1
|
|
0.750% due |
FIT4 |
+25 |
|
|
8.125% |
CUSIP: 931427AW8 |
|
4.375% due |
FIT4 |
+50 |
|
|
3.200% |
CUSIP: 931427AS7 |
|
3.875% UST |
FIT1 |
+0 |
|
|
4.500% |
CUSIP: 931427AB4 |
|
4.250% UST |
FIT1 |
+20 |
|
|
4.400% Notes due |
CUSIP: 931422AK5
|
|
5.000% UST |
FIT1 |
+20 |
|
|
4.800% |
CUSIP: 931427AC2
|
|
5.000% UST |
FIT1 |
+0 |
|
|
4.650% |
CUSIP: 931427AR9
|
|
5.000% UST |
FIT1 |
+0 |
|
|
4.100% |
CUSIP: 931427AT5 |
|
4.625% UST |
FIT1 |
+20 |
|
|
|
____________________ |
||||||
(1) |
The applicable page on Bloomberg from which the Dealer Manager (as defined below) will quote the bid side price of the applicable |
||||||
(2) |
Per |
||||||
(3) |
Included in the Total Consideration for Notes tendered and accepted for purchase on or prior to the Early Tender Deadline. |
||||||
(4) |
The CUSIP numbers and ISIN numbers referenced in this press release are included solely for the convenience of holders. None of the |
General Information
The Offeror's obligations to complete the Tender Offer and Consent Solicitation are subject to and conditioned upon the following having occurred or having been waived by us with respect to such Offer: (1) the satisfaction of the Merger Condition, and (2) the satisfaction of the General Conditions (each as described in the Offer to Purchase and Consent Solicitation Statement). Each Offer and Consent Solicitation is a separate offer and are not conditioned on any other Offer or Consent Solicitation. There can be no assurance that either of the Tender Offer or Consent Solicitation will be consummated. The Offeror may amend, extend or terminate the Tender Offer and Consent Solicitation, in its sole discretion.
The Offeror intends to fund the Total Consideration (inclusive of the Early Tender Payment) and the Tender Offer Consideration (including, in each case, accrued and unpaid interest), plus all related fees and expenses, using proceeds from the financing transactions to fund the Merger. Notes that are tendered and accepted in the Offer will cease to be outstanding and will be cancelled.
The terms and conditions of the Tender Offer are described in the Offer to Purchase and Consent Solicitation Statement.
Any Notes not tendered and purchased pursuant to the Tender Offer will remain outstanding. If the Consents are received with respect to a series of Notes, and the Proposed Amendments become operative with respect to the Indenture for such series of Notes, then the applicable Notes that are not purchased pursuant to the Tender Offer will be subject to the Proposed Amendments.
To the extent any Notes remain outstanding, the Parent may cause the Company to redeem such Notes after the closing of the Merger and the consummation of the Tender Offer in accordance with the terms of the Indentures as amended by the Proposed Amendments, as applicable. Alternatively, the Parent may cause the Company to defease such Notes, in which case holders of such Notes will continue to receive interest payment on each scheduled interest payment date and principal on the stated maturity date but will not benefit from any restrictive covenants and such Notes will not be subject to any change of control offer in connection with the Merger. Finally, the Parent may leave outstanding any outstanding Notes after the closing of the Merger and the consummation of the Tender Offer. The Parent has the right to make any and all decisions with respect to any outstanding Notes in its sole discretion, subject to compliance with the terms of the agreements governing its indebtedness.
This press release is for informational purposes only. The Tender Offer and Consent Solicitation are being made solely by the Offer to Purchase and Consent Solicitation Statement. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful. The Tender Offer and Consent Solicitation are not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In any jurisdiction in which the securities laws or blue sky laws require the Tender Offer or Consent Solicitation to be made by a licensed broker or dealer, the Tender Offer and Consent Solicitation will be deemed to be made on behalf of the Offeror by the Dealer Manager and Solicitation Agent, or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction.
None of the Offeror, the Company, the Trustee (in any of its capacities), the Depositary and Information Agent, the Dealer Manager and Solicitation Agent or any of their respective affiliates makes any recommendation as to whether holders should tender or refrain from tendering their Notes, and no person or entity has been authorized by any of them to make such a recommendation. Holders must make their own decision as to whether to tender Notes and, if so, the principal amount of the Notes to tender.
Forward-Looking Statements
This Offer to Purchase and Consent Solicitation Statement and certain statements made from time to time by us, the Company and our and their respective representatives contain or incorporate by reference certain "forward-looking statements" within the meaning of the federal securities laws. All statements other than statements of historical facts are forward-looking statements. In many cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or other similar words. These forward-looking statements are only predictions. These statements relate to future events and involve known and unknown risks, uncertainties and other important factors that may cause the actual outcomes to materially differ from those expressed or implied by these forward-looking statements. New factors could emerge from time to time and it is not possible for us to predict all such factors. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as guarantees of future events. These forward-looking statements speak only as of the date made and are not guarantees of future performance of results. We expressly disclaim any obligation or undertaking to release any updates or revisions to any forward-looking statement contained or incorporated by reference herein to reflect any change in expectations with regard thereto or any change of events, conditions or circumstances on which any such statement was based, except as required by law.
SOURCE